Minimally Invasive Surgery Devices Market Share

ID: MRFR/HC/6403-HCR

200 Pages

Rahul Gotadki

October 2025

Minimally Invasive Surgery Devices Market Research Report By Application (General Surgery, Cardiothoracic Surgery, Gynecological Surgery, Urological Surgery, Orthopedic Surgery), By Product Type (Endoscopes, Robotic Surgery Systems, Laparoscopic Surgical Instruments, Visualization Systems, Access Devices), By End-use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Technology (Video-Assisted Thoracoscopic Surgery, Transcatheter Aortic Valve Replacement, Natural Orifice Transluminal Endoscopic Surgery), and By Regional (North A... read more

Minimally Invasive Surgery Devices Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Share

Minimally Invasive Surgery Devices Market Share Analysis

In the fast-changing Tire Changing Machines Market, firms use various techniques to gain market share. Companies often differentiate their tire changing machines by providing unique features and modern technology. Differentiating with automated systems, ergonomic designs, or cutting-edge tire mounting/dismounting capabilities helps organizations stand out and meet tire service providers' demands. Companies may attract loyal customers searching for innovative and efficient tire changing equipment by offering unique value offers.

Cost leadership is another key Tire Changing Machines Market strategy. Companies using this method optimize production processes, supply networks, and operational efficiency to become the most cost-efficient manufacturers. These firms target price-sensitive clients and increase market share by selling high-quality tire changing equipment at competitive costs. Cost leadership demands balancing cost reduction and product quality to satisfy customers.

Some organizations use niche targeting to target certain Tire Changing Machines Market segments. Specialized machinery like heavy-duty commercial vehicles or high-performance sports automobiles may be developed. By meeting the needs of these specialized markets, organizations may become specialists and gain loyal customers. Niche targeting helps organizations stand out in competitive markets by focusing marketing.

Strategic alliances and collaborations can affect Tire Changing Machines Market share positioning. Automotive manufacturers, tire suppliers, and other automotive service providers may partner with companies. Collaborations may result in integrated solutions, cooperative marketing, or exclusive distribution agreements, increasing the firms' reach and market advantage.

Customer-centricity is key to Tire Changing Machines Market share positioning. Companies that provide dependable goods, extensive assistance, and user-friendly designs are likely to retain customers. Companies remain current and retain a good reputation by understanding tire service providers' changing demands and applying client input into product development.

Digital technologies are changing Tire Changing Machines market share. Companies are using digitalization to improve equipment functionality via touchscreen interfaces, remote diagnostics, and connection. E-commerce platforms let firms reach more customers, improve distribution, and provide simple online shopping. Digital advancements boost tire changing machine efficiency and customer experience, giving companies a competitive advantage.

In conclusion, the Tire Changing Machines Market is highly competitive and technologically advanced. Effective market share positioning requires differentiation, cost leadership, niche targeting, strategic alliances, customer-centricity, and digital integration. Companies who successfully manage these techniques and adapt to the changing tire service sector will likely dominate the Tire Changing Machines Market.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected growth of the Minimally-Invasive Surgery Devices market?

The Minimally-Invasive Surgery Devices market is the expected increase in total market value of 40.43 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Minimally-Invasive Surgery Devices market?

Minimally-Invasive Surgery Devices market size was valued at approximately 15.35 billion USD in 2024. This figure will reach 40.43 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Minimally-Invasive Surgery Devices market?

Minimally-Invasive Surgery Devices market is expected to grow at a CAGR of 9.2% between 2025 and 2035.

How much will the Minimally-Invasive Surgery Devices market be worth by 2035?

Minimally-Invasive Surgery Devices market is expected to be worth of 40.43 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Minimally-Invasive Surgery Devices market perform over the next 10 years?

Over the next 10 years the Minimally-Invasive Surgery Devices market is expected to shift from usd billion 15.35 to 40.43 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

What was the market size for the Minimally Invasive Surgery Devices Market in 2024?

The Minimally Invasive Surgery Devices Market was valued at 35.59 USD billion in 2024.

Which application segment will dominate the market in 2024, and what will its projected value be in 2035?

The General Surgery segment dominated the market, valued at 10.5 USD billion in 2024 and projected to reach 16.25 USD billion by 2035.

What are the projected values for the Cardiothoracic Surgery application in the market for 2024 and 2035?

The Cardiothoracic Surgery application was valued at 7.2 USD billion in 2024 and is projected to grow to 11.2 USD billion by 2035.

Which region is expected to have the highest market value in 2024 and what will it be by 2035?

North America held the highest market value of 12.5 USD billion in 2024, expected to increase to 20.0 USD billion by 2035.

What was the market value for the Asia Pacific region in 2024?

The Asia Pacific region held a market value of 8.0 USD billion in 2024.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Minimally Invasive Surgery Devices Market was estimated at 15.35 USD Billion in 2024. The Minimally Invasive Surgery Devices industry is projected to grow from 16.77 USD Billion in 2025 to 40.43 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 9.2 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Minimally Invasive Surgery Devices Market is poised for substantial growth driven by technological advancements and increasing patient demand.

Technological advancements are revolutionizing the Minimally Invasive Surgery Devices Market, enhancing precision and efficiency.
North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for these devices.
Cardiothoracic surgery continues to dominate the market, whereas urological surgery is witnessing the fastest growth in demand.
The rising demand for outpatient procedures and an aging population are key drivers propelling market expansion.

Minimally Invasive Surgery Devices Market

CAGR

9.2%

Market Size & Forecast

2024 Market Size	15.35 (USD Billion)
2035 Market Size	40.43 (USD Billion)
CAGR (2025 - 2035)	9.2%
Largest Regional Market Share in 2024	North America

Major Players

Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)

Market Trends

The Minimally Invasive Surgery Devices Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing preference for less invasive procedures among patients. This market encompasses a wide array of devices designed to facilitate surgical interventions with minimal disruption to the body, thereby promoting quicker recovery times and reduced hospital stays. As healthcare providers continue to prioritize patient outcomes, the demand for innovative surgical solutions is likely to rise, fostering a competitive landscape where manufacturers strive to enhance their offerings. Furthermore, the integration of robotics and imaging technologies into surgical practices appears to be reshaping traditional methodologies, suggesting a shift towards more precise and efficient surgical techniques. In addition to technological advancements, the Minimally Invasive Surgery Devices Market is influenced by evolving regulatory frameworks and growing awareness regarding the benefits of minimally invasive procedures. Healthcare professionals are increasingly recognizing the advantages of these techniques, which may lead to broader adoption across various surgical specialties. As the market evolves, it seems poised for sustained growth, with potential opportunities emerging in developing regions where access to advanced surgical technologies is expanding. Overall, the Minimally Invasive Surgery Devices Market reflects a dynamic interplay of innovation, regulatory changes, and shifting patient preferences, indicating a promising future for the sector.

Technological Advancements

The Minimally Invasive Surgery Devices Market is witnessing rapid technological innovations, particularly in robotics and imaging systems. These advancements enhance precision and efficiency during surgical procedures, potentially leading to improved patient outcomes.

Regulatory Developments

Evolving regulatory frameworks are shaping the Minimally Invasive Surgery Devices Market. Stricter guidelines and approvals may influence the introduction of new devices, ensuring safety and efficacy while fostering innovation.

Increased Patient Awareness

Growing awareness among patients regarding the benefits of minimally invasive procedures is driving demand in the Minimally Invasive Surgery Devices Market. As individuals seek less traumatic surgical options, healthcare providers are adapting to meet these expectations.

Minimally Invasive Surgery Devices Market Market Drivers

Technological Advancements

The Global Minimally Invasive Surgery Devices Market Industry is experiencing rapid growth due to continuous technological advancements. Innovations such as robotic-assisted surgery, advanced imaging techniques, and enhanced surgical instruments are transforming surgical procedures. For instance, the integration of artificial intelligence in surgical devices is improving precision and outcomes. As a result, the market is projected to reach 35.6 USD Billion in 2024, reflecting a growing demand for sophisticated surgical solutions. These advancements not only enhance patient safety but also reduce recovery times, making minimally invasive procedures more appealing to healthcare providers and patients alike.

Market Segment Insights

By Application: Cardiothoracic Surgery (Largest) vs. Urological Surgery (Fastest-Growing)

In the Minimally Invasive Surgery Devices Market, Cardiothoracic Surgery holds the largest share among the various applications due to its established adoption of advanced surgical devices that facilitate heart and lung procedures with minimal invasiveness. This segment benefits from a growing number of cardiac conditions and an increasing elderly population, making it a critical area for device manufacturers. On the other hand, Urological Surgery has emerged as the fastest-growing segment as technological advancements enhance surgical precision and patient outcomes. The rising incidence of urological diseases, along with a growing preference for minimally invasive techniques, drives the demand for innovative devices in this field.

Cardiothoracic Surgery: Dominant vs. Urological Surgery: Emerging

Cardiothoracic Surgery represents a dominant force in the Minimally Invasive Surgery Devices Market, characterized by a broad range of applications from coronary artery bypass to valve repair procedures. Its strong market position is attributed to the high effectiveness and shorter recovery times associated with minimally invasive techniques. Conversely, Urological Surgery, while still emerging, is witnessing rapid growth due to technological innovations such as robotic-assisted surgeries and improved imaging techniques. These advancements enable surgeons to perform complex procedures with enhanced accuracy and reduced patient trauma. As awareness of minimally invasive options increases, Urological Surgery is set to further expand its footprint in the surgery devices market, potentially challenging the established leaders over time.

By Device Type: Endoscopes (Largest) vs. Surgical Robots (Fastest-Growing)

In the Minimally Invasive Surgery Devices Market, endoscopes hold the largest share due to their widespread use and versatility in procedures. These devices enable surgeons to perform complex operations with minimal incisions, enhancing recovery time and improving patient outcomes. Other segments like laparoscopic instruments and access devices also contribute significantly, but they remain behind endoscopes in market share. Surgical robots, while smaller in share, are rapidly gaining traction as more healthcare facilities adopt this advanced technology for intricate surgeries. Growth trends in the minimally invasive surgery devices market are being driven by technological advancements and an increasing preference for less invasive procedures among patients. The market for surgical robots is anticipated to expand rapidly, influenced by the growing demand for precision and automation in surgical procedures. As healthcare costs rise, the efficiency and effectiveness offered by minimally invasive devices are propelling their adoption in surgical settings, indicating robust future growth for this segment.

Endoscopes (Dominant) vs. Surgical Robots (Emerging)

Endoscopes have established themselves as the dominant technology in the Minimally Invasive Surgery Devices Market due to their capability to facilitate a broad range of diagnostic and therapeutic procedures. Their design allows for direct visualization of internal organs, making them indispensable in surgeries such as gastrointestinal and pulmonary interventions. On the other hand, surgical robots are emerging rapidly, characterized by enhanced surgical precision and reduced recovery time for patients. These advanced systems offer surgeons unparalleled control and flexibility, thereby driving their adoption in complex surgical scenarios. With an increasing number of training programs and technological advancements, surgical robots are set to revolutionize the landscape of minimally invasive surgeries.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Minimally Invasive Surgery Devices Market, hospitals represent the largest end-user segment, leveraging advanced surgical technologies and comprehensive patient care. Their extensive infrastructure and ability to invest in cutting-edge devices contribute significantly to their market share. Following hospitals, ambulatory surgical centers (ASCs) are gaining traction, attributed to their cost-effectiveness and efficiency in performing same-day procedures. As healthcare shifts toward outpatient care, ASCs are rapidly capturing a larger portion of the market.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals are the dominant end users in the minimally invasive surgery devices market, characterized by their high patient throughput and extensive surgical departments. They have the resources to integrate a wide array of advanced surgical devices, thereby enhancing patient outcomes. Conversely, ambulatory surgical centers represent an emerging segment, focusing on outpatient procedures that allow patients to recover at home. ASCs feature lower overhead costs and shorter waiting times, making them increasingly popular among patients and insurers. This focus on patient-centered care positions ASCs as a vital player in the minimally invasive surgery landscape, poised for significant growth.

Get more detailed insights about Minimally-Invasive Surgery Devices Market Research Report - Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America is poised to maintain its leadership in the Minimally Invasive Surgery Devices Market, holding a significant market share of 7.5 in 2024. The region's growth is driven by increasing demand for advanced surgical techniques, rising healthcare expenditures, and favorable reimbursement policies. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing patient outcomes and operational efficiencies. The competitive landscape in North America is robust, featuring key players such as Medtronic, Johnson & Johnson, and Intuitive Surgical. These companies are at the forefront of technological advancements, focusing on product development and strategic partnerships to expand their market presence. The U.S. remains the largest market, supported by a well-established healthcare infrastructure and a high prevalence of chronic diseases, driving the need for minimally invasive procedures.

Europe : Emerging Market with Growth Potential

Europe's Minimally Invasive Surgery Devices Market is projected to grow significantly, with a market size of 4.5 in 2024. The region benefits from a growing aging population, increasing prevalence of lifestyle-related diseases, and advancements in surgical technologies. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing safety and efficacy standards, thereby boosting market confidence and adoption rates across member states. Leading countries in Europe include Germany, France, and the UK, where major players like B. Braun Melsungen AG and Olympus Corporation are actively innovating. The competitive landscape is characterized by a mix of established firms and emerging startups, focusing on developing cutting-edge solutions. The European market is increasingly collaborative, with partnerships aimed at enhancing product offerings and expanding market reach, reflecting a dynamic and evolving industry landscape.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific region is witnessing rapid growth in the Minimally Invasive Surgery Devices Market, with a market size of 2.8 in 2024. Key growth drivers include rising healthcare awareness, increasing disposable incomes, and a growing number of surgical procedures. Governments are investing in healthcare infrastructure and promoting advanced surgical techniques, which are expected to further enhance market growth. Regulatory bodies are also streamlining approval processes to facilitate quicker market entry for innovative devices. Countries like Japan, China, and India are leading the charge in adopting minimally invasive techniques. The competitive landscape features both global giants and local manufacturers, with companies like Olympus Corporation and Stryker playing pivotal roles. The region's market is characterized by a diverse range of products and technologies, catering to various surgical specialties, thus driving competition and innovation in the sector.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region is gradually emerging in the Minimally Invasive Surgery Devices Market, with a market size of 0.55 in 2024. Growth is driven by increasing healthcare investments, a rising prevalence of chronic diseases, and a growing demand for advanced surgical solutions. However, challenges such as limited healthcare infrastructure and regulatory hurdles may impede faster growth. Governments are focusing on improving healthcare access and quality, which is expected to positively impact market dynamics. Leading countries in this region include South Africa and the UAE, where there is a growing presence of key players like Abbott Laboratories and Boston Scientific. The competitive landscape is evolving, with both international and local companies striving to capture market share. As healthcare systems improve, the demand for minimally invasive procedures is expected to rise, fostering innovation and investment in the sector.

Key Players and Competitive Insights

The Minimally Invasive Surgery Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing patient preference for less invasive procedures, and a growing emphasis on cost-effective healthcare solutions. Key players such as Medtronic (US), Johnson & Johnson (US), and Intuitive Surgical (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on innovation through the development of advanced robotic-assisted surgical systems, while Johnson & Johnson (US) emphasizes strategic partnerships to expand its product portfolio. Intuitive Surgical (US) continues to lead in robotic surgery, leveraging its established da Vinci system to capture a larger market share, thereby shaping a competitive environment that prioritizes technological superiority and operational efficiency.

The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. This competitive structure allows for a diverse range of products and services, with key players collectively influencing market trends through their strategic initiatives. The emphasis on supply chain optimization and localized production is likely to enhance responsiveness to market demands, thereby fostering a more resilient operational framework.

In November 2025, Medtronic (US) announced the launch of its latest robotic-assisted surgical platform, which integrates AI capabilities to enhance surgical precision. This strategic move is significant as it not only reinforces Medtronic's commitment to innovation but also positions the company to better compete against emerging players in the market. The integration of AI is expected to streamline surgical workflows, potentially leading to improved patient outcomes and reduced recovery times.

In October 2025, Johnson & Johnson (US) entered into a partnership with a leading telehealth provider to enhance remote surgical consultations. This collaboration is indicative of the company's strategy to leverage digital health technologies, thereby expanding its reach and improving patient access to minimally invasive procedures. Such initiatives may enhance the overall patient experience and drive adoption rates for their surgical devices.

In September 2025, Intuitive Surgical (US) expanded its global footprint by establishing a new manufacturing facility in Europe. This strategic expansion is likely to facilitate quicker distribution of its products across the region, thereby enhancing its competitive edge. The facility is expected to support increased production capacity, which aligns with the growing demand for robotic-assisted surgeries in Europe.

As of December 2025, the Minimally Invasive Surgery Devices Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is becoming more pronounced. As the market evolves, differentiation will likely hinge on the ability to deliver cutting-edge solutions that enhance surgical outcomes and patient satisfaction.

Key Companies in the Minimally Invasive Surgery Devices Market include

Industry Developments

In order to facilitate difficult thoracic and urologic operations, Intuitive Surgical announced in February 2025 that it will introduce a next-generation da Vinci robotic system with improved tactile feedback and AI-assisted navigation.

Following prior FDA certification, CMR Surgical extended its Versius robotic platform across Latin America and Southeast Asia in March 2025 in response to the rising need for small, reasonably priced minimally invasive procedures. The FDA approved Johnson & Johnson's Ethicon division's powered laparoscopic stapler with integrated real-time tissue sensing in October 2024.

The device is intended to improve accuracy and lower intraoperative mistakes. The first 5 mm wristed, articulating laparoscopic tool line, the ArtiSential 5, was introduced by LivsMed in October 2024. Its finer instrumentation gives surgeons more maneuverability. The FDA approved Virtual Incision Corporation's MIRA mini-RAS system in February 2024.

It is a small robotic device for adult colectomy that integrates easily into current operating rooms. Furthermore, Momentis Surgical, founded in Israel, received FDA 510(k) approval in March 2025 for their Anovo single-port robotic device, which is intended to treat ventral hernias.

A significant step toward automation in gastrointestinal procedures was finally taken in February 2025 when state-of-the-art academic teams presented a semi-automated, contactless robot-assisted laser tissue soldering device for in-vivo colon incision closure in pigs.

Future Outlook

Minimally Invasive Surgery Devices Market Future Outlook

The Minimally Invasive Surgery Devices Market is projected to grow at a 9.2% CAGR from 2024 to 2035, driven by technological advancements, increasing patient demand, and cost-effectiveness.

New opportunities lie in:

Expansion of robotic-assisted surgical systems in outpatient settings.
Development of advanced imaging technologies for enhanced surgical precision.
Integration of AI-driven analytics for personalized surgical planning.

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Minimally Invasive Surgery Devices Market End User Outlook

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research Institutions

Minimally Invasive Surgery Devices Market Application Outlook

Cardiothoracic Surgery
Gastrointestinal Surgery
Urological Surgery
Orthopedic Surgery
Gynecological Surgery

Minimally Invasive Surgery Devices Market Device Type Outlook

Endoscopes
Surgical Robots
Laparoscopic Instruments
Access Devices
Visualization Systems

Report Scope

MARKET SIZE 2024	15.35(USD Billion)
MARKET SIZE 2025	16.77(USD Billion)
MARKET SIZE 2035	40.43(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.2% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)
Segments Covered	Application, Device Type, End User
Key Market Opportunities	Integration of advanced robotics and artificial intelligence enhances precision in the Minimally Invasive Surgery Devices Market.
Key Market Dynamics	Technological advancements and regulatory changes drive growth in the Minimally Invasive Surgery Devices Market.
Countries Covered	North America, Europe, APAC, South America, MEA